Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association
|
March 14, 2008
An induction programme for health visitors
Stephanie Honey, Claire Walton
Disability and Rehabilitation. Assistive Technology
|
October 18, 2013
Comparison of activities of daily living (ADLs) in two different one arm drive wheelchairs: a study of individuals/participants with hemiplegia
Anne Mandy, Claire Walton, Jon Michaelis
Sensors (Basel, Switzerland)
|
July 9, 2022
Defense against Adversarial Swarms with Parameter Uncertainty
Claire Walton, Isaac Kaminer, Qi Gong, et al.
Sensors (Basel, Switzerland)
|
March 10, 2022
Bernstein Polynomial-Based Method for Solving Optimal Trajectory Generation Problems
Calvin Kielas-Jensen, Venanzio Cichella, Thomas Berry, et al.
ACR Open Rheumatology
|
August 31, 2025
Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab
Michael E Wechsler, Nancy Agmon-Levin, David R W Jayne, et al.
Plos One
|
May 24, 2024
A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors
Annika Åstrand, Cecilia Wingren, Claire Walton, et al.
The British Journal of Dermatology
|
February 17, 2024
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial
Sabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2025
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
Parameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.
The New England Journal of Medicine
|
February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Michael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Annals of the Rheumatic Diseases
|
August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Peter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association
|
March 14, 2008
An induction programme for health visitors
Stephanie Honey, Claire Walton
Disability and Rehabilitation. Assistive Technology
|
October 18, 2013
Comparison of activities of daily living (ADLs) in two different one arm drive wheelchairs: a study of individuals/participants with hemiplegia
Anne Mandy, Claire Walton, Jon Michaelis
Sensors (Basel, Switzerland)
|
July 9, 2022
Defense against Adversarial Swarms with Parameter Uncertainty
Claire Walton, Isaac Kaminer, Qi Gong, et al.
Sensors (Basel, Switzerland)
|
March 10, 2022
Bernstein Polynomial-Based Method for Solving Optimal Trajectory Generation Problems
Calvin Kielas-Jensen, Venanzio Cichella, Thomas Berry, et al.
ACR Open Rheumatology
|
August 31, 2025
Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab
Michael E Wechsler, Nancy Agmon-Levin, David R W Jayne, et al.
Plos One
|
May 24, 2024
A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors
Annika Åstrand, Cecilia Wingren, Claire Walton, et al.
The British Journal of Dermatology
|
February 17, 2024
Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial
Sabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 22, 2025
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
Parameswaran K Nair, Bernhard Hellmich, Arnaud Bourdin, et al.
The New England Journal of Medicine
|
February 23, 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Michael E Wechsler, Parameswaran Nair, Benjamin Terrier, et al.
Annals of the Rheumatic Diseases
|
August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Peter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
Page
of 1